Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ailing Gui
Observed name:
Ai-ling Gui
Institutions:
Shanghai Medical College of Fudan University,
Fudan University
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University
ORCID:
0009-0001-1874-5612
Observed ORCID:
0009-0001-1874-5612
OpenAlex ID:
A5037476884
Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma
2022
·
Xi-Ya Li
, Ji-Chuan Wu
, et al.
·
Leukemia
·
40
PDF
MORTALIN-Ca2+ axis drives innate rituximab resistance in diffuse large B-cell lymphoma
2022
·
Qi Sun
, Ying Ye
, et al.
·
Cancer Letters
·
17
A Regulatory Loop Involving miR-200c and NF-κB Modulates Mortalin Expression and Increases Cisplatin Sensitivity in an Ovarian Cancer Cell Line Model
2022
·
Xin Huang
, Yichen Yan
, et al.
·
International Journal of Molecular Sciences
·
12
PDF
Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphoma
2022
·
Shi Qiu
, Yizhen Liu
, et al.
·
Journal of Cancer
·
8
PDF
Serum miR‐146a level is a potential biomarker in predicting the outcome of diffuse large B‐cell lymphoma
2022
·
Xin Huang
, Ailing Gui
, et al.
·
Asia-Pacific Journal of Clinical Oncology
·
6
Mitochondria-specific peptide amphiphiles induce mitochondrial dysfunction and peripheral T-cell lymphomas (PTCL) damage
2022
·
Qi Sun
, Ailing Gui
, et al.
·
Annals of Translational Medicine
·
4
PDF
USP1–TRAF2 axis–regulated mortalin stability mediates chemoresistance by disrupting calcium transport in peripheral T-cell lymphoma
2025
·
Ailing Gui
, Yichen Yan
, et al.
·
Proceedings of the National Academy of Sciences
·
3
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era
2022
·
Jia Jin
, Ailing Gui
, et al.
·
International Journal of Hematology
·
3
Zanubrutinib potentiates polatuzumab vedotin efficacy in DLBCL with concurrent CD79b upregulation
2026
·
Xiaolong Zhou
, Jingjing Li
, et al.
·
Annals of Hematology
·
1
Reduced OTUD7B expression correlates with poor prognosis in PTCL via non-canonical NF-κB
2024
·
Feng Chen
, Shi Qiu
, et al.
·
International Journal of Hematology
·
1
Intracellular COMP drives ovarian cancer progression through AKT/ERK signaling with concomitant pathway-dependent transgelin upregulation
2026
·
Yuxin Zhao
, Junyi Zhang
, et al.
·
Acta Biochimica et Biophysica Sinica
Elevated FGR protein expression identifies a high-risk subset of diffuse large B-cell lymphoma and a potential therapeutic target
2026
·
Kexin Shen
, Shiyu Jiang
, et al.
·
Frontiers in Oncology
PDF
Prognostic Significance of Deubiquitinase OTUD7B in NK/T‐Cell Lymphoma
2025
·
Yizhen Liu
, Shujuan Wen
, et al.
·
Asia-Pacific Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
13
Citation count:
95
H-index:
5
I10-index:
3
Year
Topic
Type